Report period | 2019 | 2020 | 2021 | 2022 | 2023 | Q2 24 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, ₽ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Name | Issue size | Price | Yield |
---|---|---|---|
ISKJ BO-01 (RUB) | 300,000 pcs. | 83.79% | 20.76% |
Company name | Artgen |
---|---|
Tags | #biotechnology, #pharmacy, #innovations of the russia |
Sector | Health Care / Health Care Equipment & Services / Health Care Providers & Services / Health Care Services |
Business address | RF, g. Moskva |
Mailing address | 117036, g. Moskva, prospekt 60-letiya Oktyabrya, d. 10A, etazh 3, pom. 24 |
CEO | Masyuk Sergey Vladimirovich |
Phone | +7 (495) 646-80-76 |
Website | artgen.ru |
Information disclosure | e-disclosure.ru |